Why Moderna Was a Big Winner on Friday
Friday was a good day for now-famous biotech Moderna (NASDAQ: MRNA), whose mRNA-1273 coronavirus vaccine continues to inoculate Americans. The company's shares rose by 7.7% on the day, thanks largely to the latest pronouncement by a major health authority.
Indicating how much progress has been made -- in no small part thanks to Moderna's vaccine -- the U.S. Centers For Disease Control and Prevention (CDC) loosened its guidance on mask-wearing Thursday.
Image source: Getty Images.
Source Fool.com


